Zobrazeno 1 - 10
of 85
pro vyhledávání: '"U. Säwe"'
Autor:
Åke Westin, U Säwe, André P. Perruchoud, Jean-Pierre Zellweger, Tobias Danielsson, A Robidou, X van Biljon, Chris T. Bolliger
Publikováno v:
BMJ. 321:329-333
Objectives: To determine whether use of an oral nicotine inhaler can result in long term reduction in smoking and whether concomitant use of nicotine replacement and smoking is safe. Design: Double blind, randomised, placebo controlled trial. Four mo
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 75:551-554
This study evaluated long-term effects of 12 weeks of supervised training, of at least 45 minutes duration with two sessions per week, on physical performance and psychological well-being after myocardial infarction (MI). Sixty-nine patients were ran
Autor:
J, Le Houezec, U, Säwe
Publikováno v:
Journal des maladies vasculaires. 28(5)
Tobacco use causes enormous morbidity and mortality because of the high risk of smoking-related diseases and the high prevalence of cigarette smoking. Existing smoking cessation methods only help motivated smokers who are ready to quit, but the vast
Autor:
E, Fornai, M, Desideri, F, Pistelli, L, Carrozzi, R, Puntoni, S, Avino, G, Gustavsson, U, Säwe, G, Viegi, C, Giuntini
The aim of this retrospective analysis was to assess the extent of smoking reduction in smokers who were compliant to a smoking cessation trial with nicotine patch, and failed to completely quit smoking. Out of 297 smokers in total, 237 participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1cfc08dc826ddaefe20d30900fe982f5
http://hdl.handle.net/11568/815470
http://hdl.handle.net/11568/815470
Publikováno v:
Rhinology. 36(3)
Thirty-three subjects with chronic rhinitis used nicotine nasal spray in an open study as an aid in smoking cessation. Thirty-eight percent of them were completely abstinent at 12 weeks, whereas 35% were completely abstinent at 20 weeks. The nasal sp
Autor:
R. Puntoni, Giovanni Viegi, G Gustavsson, F Maggiorelli, A. Corlando, Carlo Giuntini, L Carrozzi, E. Fornai, Paolo Paoletti, U Säwe
Nicotine replacement by transdermal patches is more effective than placebo in smoking cessation, but has a low success rate after one year (9-18%). We tested whether this was attributed to insufficient nicotine replacement. We conducted a randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512136f396171e5d61b88185bd0697e1
http://hdl.handle.net/11568/1083587
http://hdl.handle.net/11568/1083587
Publikováno v:
Journal of the Royal College of Physicians of London. 29(5)
We had the unique opportunity to study the effects of transdermal nicotine on markers of haemostasis and serum lipids in patients with ulcerative colitis; all were non-smokers and were given transdermal nicotine to assess its value in maintenance the
Publikováno v:
Archives of internal medicine. 153(16)
To determine the effectiveness of a 16-hour transdermal nicotine patch in assisting smokers to stop smoking, when used in a primary medical practice model.A single-site, randomized, double-blind, out-patient, parallel-group, placebo-controlled trial
Publikováno v:
Ugeskrift for laeger. 154(5)
The use of nicotine chewing gum combined with psychological support improves the success rate in stopping smoking. We studied the safety and efficacy of a transdermal nicotine patch in stopping smoking. We conducted a double-blind randomized study co
Autor:
S. Hofvendahl, Herman O. Klein, L. Mogensen, G. Levi, R. Valentini, O. Nyquist, Gunnar Törnell, U. Säwe, Bengt Jönsson, C. Helmers, L. Gregorini, Lawrence D. Horwitz, P. O. Wester, Richard J. Goss, Arnaldo Libretti, Vernon S. Bishop, A. Rovetta, Harvey J. Berger, C. Proto, Alfred Szamosi, T. Lundman, John E. Dittmer
Publikováno v:
Cardiology. 58:I-IV